cardiology careers collections past issues search home
     

Right arrow Help viewing high resolution images
Right arrow Return to article

Please click here to obtain permission to reproduce this image.

Click on image to view larger version.



Figure 1 Anti-factor Xa (anti-Xa) levels during the first 24 h of treatment with subcutaneous (SQ) alone (solid circles) or intravenous +SQ (open squares) enoxaparin. Data are presented as the mean value ± SEM. Dotted lines represent the lower and upper therapeutic range (0.5 and 1.0 U/ml, respectively). Significant differences (p < 0.05) using the t test between the two groups are marked with an asterisk.





Right arrow Return to article

 
  cardiology careers collections past issues search home